시장보고서
상품코드
1472035

골반장기탈출증 치료 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 지역별 전망 및 예측(2024-2031년)

Pelvic Organ Prolapse Repair Market - Global Pelvic Organ Prolapse Repair Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2031 -

발행일: | 리서치사: Fairfield Market Research | 페이지 정보: 영문 202 Pages | 배송안내 : 2-5일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 골반 장기탈출증(POP) 치료 시장 규모는 2024년 4억 2,000만 달러에서 2031년 6억 달러에 달할 것으로 예측됩니다. 이 시장은 2024년부터 2031년까지 5.23%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

시장 확대는 몇 가지 매우 중요한 요인에 의해 촉진되고 있습니다. 첫째, 세계 인구의 고령화와 출산 및 호르몬 변화로 인해 골반 장기 탈출증의 유병률이 증가하고 있습니다. 인구 통계가 계속 변화함에 따라 복원 수술에 대한 수요도 급증할 것으로 예상됩니다.

둘째, 수술 기술과 의료기기의 눈부신 발전은 골반장기탈출증 치료의 상황을 완전히 바꾸어 놓았습니다. 복강경 수술과 로봇 보조 수술을 포함한 최소 침습 수술의 혁신은 기존 개복 수술에 비해 회복 시간을 단축하고 합병증 발생률을 낮추며 환자 만족도를 향상시켰습니다.

또한, 골반저 장애에 대한 인식이 높아지고 치료 옵션이 늘어나면서 골반장기탈출증에 대한 의료 지원을 받으려는 환자들의 의욕이 증가하고 있습니다. 의료 교육, 옹호 활동, 의료 서비스 접근성 향상으로 조기 진단과 치료가 더욱 촉진되어 시장 성장을 가속하고 있습니다.

이 보고서는 세계 골반장기탈출증 치료 시장에 대해 조사했으며, 시장 개요와 함께 치료별/용도별/최종사용자별/지역별 동향, 시장 진출기업의 경쟁 동향 등을 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

  • 시장 정의와 세분화
  • 시장 역학
  • 밸류체인 분석
  • Porter의 Five Forces 분석
  • COVID-19의 영향 분석
  • 우크라이나·러시아 분쟁의 영향
  • 경제 개요
  • PESTLE 분석

제3장 세계의의 골반 장기탈출증(POP) 치료 시장 전망, 2019년-2031년

  • 세계의 골반 장기탈출증(POP) 치료 시장 전망, 치료별, 금액(10억 달러), 2019년-2031년
  • 세계의 골반 장기탈출증(POP) 치료 시장 전망, 용도별, 금액(10억 달러), 2019년-2031년
  • 세계의 골반 장기탈출증(POP) 치료 시장 전망, 최종사용자별, 금액(10억 달러), 2019년-2031년
  • 세계의 골반 장기탈출증(POP) 치료 시장 전망, 지역별, 금액(10억 달러), 2019년-2031년

제4장 북미의 골반 장기탈출증(POP) 치료 시장 전망, 2019년-2031년

제5장 유럽의 골반 장기탈출증(POP) 치료 시장 전망, 2019년-2031년

제6장 아시아태평양의 골반 장기탈출증(POP) 치료 시장 전망, 2019년-2031년

제7장 라틴아메리카의 골반 장기탈출증(POP) 치료 시장 전망, 2019년-2031년

제8장 중동 및 아프리카의 골반 장기탈출증(POP) 치료 시장 전망, 2019년-2031년

제9장 경쟁 구도

  • 제조업체별과 용도별 히트맵
  • 기업의 시장 점유율 분석, 2023년
  • 경쟁 대시보드
  • 기업 개요
    • Johnson & Johnson Services, Inc.
    • Coloplast A/S
    • Dipromed Srl
    • Boston Scientific Corporation
    • PFM medical ag
    • Promedon Group
    • Caldera Medical
    • Cook Medical
    • Medgyn Products, Inc.
    • Cooper Surgical, Inc.
    • DIMA S.L.
    • Digitimer Ltd.
    • Bray Group Ltd.
    • Medesign Ingenieur-Consulting GmbH
    • Panpac Medical Corp.

제10장 부록

LSH 24.05.08

Global pelvic organ prolapse (POP) repair market is on track for substantial growth, with projections indicating a valuation of US$600 million by 2031, soaring from US$420 million in 2024. This impressive expansion is anticipated to occur at a compound annual growth rate (CAGR) of 5.23% during the period spanning 2024 to 2031.

Key Growth Drivers

The market's upward trajectory is fueled by several pivotal factors. Firstly, the ageing Global population, combined with occurrences such as childbirth and hormonal changes, contribute to a heightened prevalence of pelvic organ prolapse. As demographics continue to evolve, the demand for repair procedures is expected to surge accordingly.

Secondly, significant advancements in surgical techniques and medical devices have transformed the landscape of pelvic organ prolapse repair. Innovations in minimally invasive procedures, including laparoscopic and robotic-assisted surgeries, have led to reduced recovery times, lower complication rates, and enhanced patient satisfaction compared to traditional open surgeries.

Moreover, increased awareness of pelvic floor disorders and the availability of treatment options have spurred greater patient willingness to seek medical assistance for pelvic organ prolapse. Healthcare education initiatives, advocacy efforts, and improved access to healthcare services further facilitate early diagnosis and treatment, thus propelling market growth.

Major Growth Barriers

Despite the promising outlook, the market faces notable challenges. Safety concerns surrounding certain surgical techniques and devices, particularly mesh implants, have prompted heightened regulatory scrutiny and stricter approval processes. Legal challenges stemming from product liability claims also pose hurdles to market expansion, contributing to uncertainty and potentially deterring investment in research and development.

Additionally, the emergence of alternative treatment modalities, such as pelvic floor physical therapy and lifestyle modifications, presents a restraint to market growth. Some patients may prefer conservative management approaches over surgical interventions, impacting adoption rates for pelvic organ prolapse repair procedures.

Key Trends and Opportunities

Several trends and opportunities shape the future trajectory of the pelvic organ prolapse repair market. Notably, there is a significant shift towards minimally invasive procedures, driven by associated benefits such as shorter hospital stays, faster recovery times, and reduced post-operative pain.

Furthermore, there is a growing interest in biologic and tissue-engineered implants as alternatives to synthetic mesh materials. These implants offer the potential for improved integration with host tissues and reduced risk of complications, driving research and development activity in this area.

Moreover, the development of patient-specific treatment approaches presents a significant opportunity for market players to enhance treatment outcomes and gain a competitive edge. Personalized medicine approaches, tailored to individual patient characteristics, have the potential to improve clinical outcomes and patient satisfaction.

Expansion into emerging markets, particularly in regions such as Asia-Pacific, Latin America, and the Middle East, also offers significant growth potential. Rising healthcare expenditure, improving healthcare infrastructure, and increasing awareness of pelvic floor disorders contribute to the fertile ground for market expansion in these regions.

Regional Frontrunners

Currently, North America leads the pelvic organ prolapse repair market, owing to factors such as a higher prevalence of POP, robust healthcare infrastructure, and the presence of established industry players. Europe follows closely, with a strong presence of Global industry leaders and rising awareness of pelvic floor disorders.

The Asia Pacific region is emerging as a significant player in the market, fueled by increasing awareness, a large and ageing female population, and expanding healthcare infrastructure. Medical tourism further accelerates market growth in this region.

Leaders in Global Pelvic Organ Prolapse Repair Space

Key players driving innovation and growth in the pelvic organ prolapse repair market include:

Johnson & Johnson Services, Inc.

Coloplast A/S

Dipromed Srl

Boston Scientific Corporation (American Medical Systems Inc.)

pfm medical ag

Betatech Medical

Promedon Group

Caldera Medical

Cook Medical

MEDGYN PRODUCTS, INC.

CooperSurgical, Inc.

DIMA S.L.

Digitimer Ltd

Bray Group Ltd,

medesign Ingenieur-Consulting GmbH

Panpac Medical Corp.

for.me.sa.

Bioteque America Inc.

Bliss GVS Pharma

Panpac Medical Corporation

Personal Medical Corporation

Dr. Arabin GmbH & Co.

Kangge Medical

Integra Lifesciences

Wallach Surgical Devices

Medesign

Market Segmentation

The Global Pelvic Organ Prolapse Repair Market is segmented as follows:

By Treatment:

Non-surgical:

Pessary

Pelvic Floor Muscle Therapy

Surgical:

Colpocleisis

Colporrhaphy

Sacrocolpopexy

Sacrohysteropexy

Uterosacral or Sacrospinous Ligament Fixation

By Application:

Cystocele

Urethrocele

Enterocele

Uterine Prolapse

Posterior Vaginal Wall Prolapse (dropped rectum)

By End User:

Hospitals

Specialized Clinics

Female Care Facilities

By Region:

North America

Latin America

Europe

East Asia

South Asia

Oceania

Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Pelvic Organ Prolapse Repair Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Pelvic Organ Prolapse Repair Market Outlook, 2019 - 2031

  • 3.1. Global Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Bn), 2019 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Non-surgical
        • 3.1.1.1.1. Pessary
        • 3.1.1.1.2. Pelvic Floor Muscle Therapy
      • 3.1.1.2. Surgical
        • 3.1.1.2.1. Colpocleisis
        • 3.1.1.2.2. Colporrhaphy
        • 3.1.1.2.3. Sacrocolpopexy
        • 3.1.1.2.4. Sacrohysteropexy
        • 3.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 3.2. Global Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Cystocele
      • 3.2.1.2. Urethrocele
      • 3.2.1.3. Enterocele
      • 3.2.1.4. Uterine Prolapse
      • 3.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 3.3. Global Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Hospitals
      • 3.3.1.2. Specialized Clinics
      • 3.3.1.3. Female Care Facilities
  • 3.4. Global Pelvic Organ Prolapse Repair Market Outlook, by Region, Value (US$ Bn), 2019 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Pelvic Organ Prolapse Repair Market Outlook, 2019 - 2031

  • 4.1. North America Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Bn), 2019 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. By Treatment
        • 4.1.1.1.1. Pessary
        • 4.1.1.1.2. Pelvic Floor Muscle Therapy
      • 4.1.1.2. Surgical
        • 4.1.1.2.1. Colpocleisis
        • 4.1.1.2.2. Colporrhaphy
        • 4.1.1.2.3. Sacrocolpopexy
        • 4.1.1.2.4. Sacrohysteropexy
        • 4.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 4.2. North America Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Cystocele
      • 4.2.1.2. Urethrocele
      • 4.2.1.3. Enterocele
      • 4.2.1.4. Uterine Prolapse
      • 4.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 4.3. North America Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Specialized Clinics
      • 4.3.1.3. Female Care Facilities
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 4.4.1.2. U.S. Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 4.4.1.3. U.S. Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 4.4.1.4. Canada Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 4.4.1.5. Canada Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 4.4.1.6. Canada Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Pelvic Organ Prolapse Repair Market Outlook, 2019 - 2031

  • 5.1. Europe Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Bn), 2019 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. By Treatment
        • 5.1.1.1.1. Pessary
        • 5.1.1.1.2. Pelvic Floor Muscle Therapy
      • 5.1.1.2. Surgical
        • 5.1.1.2.1. Colpocleisis
        • 5.1.1.2.2. Colporrhaphy
        • 5.1.1.2.3. Sacrocolpopexy
        • 5.1.1.2.4. Sacrohysteropexy
        • 5.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 5.2. Europe Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Cystocele
      • 5.2.1.2. Urethrocele
      • 5.2.1.3. Enterocele
      • 5.2.1.4. Uterine Prolapse
      • 5.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 5.3. Europe Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Specialized Clinics
      • 5.3.1.3. Female Care Facilities
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Pelvic Organ Prolapse Repair Market By Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.2. Germany Pelvic Organ Prolapse Repair Market By Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.3. Germany Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 5.4.1.4. U.K. Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.5. U.K. Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.6. U.K. Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 5.4.1.7. France Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.8. France Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.9. France Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 5.4.1.10. Italy Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.11. Italy Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.12. Italy Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 5.4.1.13. Turkey Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.14. Turkey Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.15. Turkey Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 5.4.1.16. Russia Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.17. Russia Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.18. Russia Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 5.4.1.19. Rest of Europe Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.20. Rest of Europe Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.21. Rest of Europe Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, 2019 - 2031

  • 6.1. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Bn), 2019 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. By Treatment
        • 6.1.1.1.1. Pessary
        • 6.1.1.1.2. Pelvic Floor Muscle Therapy
      • 6.1.1.2. Surgical
        • 6.1.1.2.1. Colpocleisis
        • 6.1.1.2.2. Colporrhaphy
        • 6.1.1.2.3. Sacrocolpopexy
        • 6.1.1.2.4. Sacrohysteropexy
        • 6.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 6.2. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Cystocele
      • 6.2.1.2. Urethrocele
      • 6.2.1.3. Enterocele
      • 6.2.1.4. Uterine Prolapse
      • 6.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 6.3. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Specialized Clinics
      • 6.3.1.3. Female Care Facilities
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 6.4.1.2. China Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 6.4.1.3. China Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 6.4.1.4. Japan Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 6.4.1.5. Japan Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 6.4.1.6. Japan Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 6.4.1.7. South Korea Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 6.4.1.8. South Korea Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 6.4.1.9. South Korea Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 6.4.1.10. India Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 6.4.1.11. India Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 6.4.1.12. India Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 6.4.1.13. Southeast Asia Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 6.4.1.14. Southeast Asia Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 6.4.1.15. Southeast Asia Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 6.4.1.16. Rest of Asia Pacific Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 6.4.1.17. Rest of Asia Pacific Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 6.4.1.18. Rest of Asia Pacific Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Pelvic Organ Prolapse Repair Market Outlook, 2019 - 2031

  • 7.1. Latin America Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Bn), 2019 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. By Treatment
        • 7.1.1.1.1. Pessary
        • 7.1.1.1.2. Pelvic Floor Muscle Therapy
      • 7.1.1.2. Surgical
        • 7.1.1.2.1. Colpocleisis
        • 7.1.1.2.2. Colporrhaphy
        • 7.1.1.2.3. Sacrocolpopexy
        • 7.1.1.2.4. Sacrohysteropexy
  • 7.2. Latin America Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Cystocele
      • 7.2.1.2. Urethrocele
      • 7.2.1.3. Enterocele
      • 7.2.1.4. Uterine Prolapse
      • 7.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 7.3. Latin America Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Specialized Clinics
      • 7.3.1.3. Female Care Facilities
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 7.4.1.2. Brazil Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 7.4.1.3. Brazil Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 7.4.1.4. Mexico Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 7.4.1.5. Mexico Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 7.4.1.6. Mexico Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 7.4.1.7. Argentina Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 7.4.1.8. Argentina Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 7.4.1.9. Argentina Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 7.4.1.10. Rest of Latin America Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 7.4.1.11. Rest of Latin America Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 7.4.1.12. Rest of Latin America Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, 2019 - 2031

  • 8.1. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Bn), 2019 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. By Treatment
        • 8.1.1.1.1. Pessary
        • 8.1.1.1.2. Pelvic Floor Muscle Therapy
      • 8.1.1.2. Surgical
        • 8.1.1.2.1. Colpocleisis
        • 8.1.1.2.2. Colporrhaphy
        • 8.1.1.2.3. Sacrocolpopexy
        • 8.1.1.2.4. Sacrohysteropexy
        • 8.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 8.2. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Cystocele
      • 8.2.1.2. Urethrocele
      • 8.2.1.3. Enterocele
      • 8.2.1.4. Uterine Prolapse
      • 8.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 8.3. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Specialized Clinics
      • 8.3.1.3. Female Care Facilities
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 8.4.1.2. GCC Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 8.4.1.3. GCC Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 8.4.1.4. South Africa Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 8.4.1.5. South Africa Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 8.4.1.6. South Africa Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 8.4.1.7. Egypt Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 8.4.1.8. Egypt Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 8.4.1.9. Egypt Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 8.4.1.10. Nigeria Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 8.4.1.11. Nigeria Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 8.4.1.12. Nigeria Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 8.4.1.13. Rest of Middle East & Africa Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 8.4.1.14. Rest of Middle East & Africa Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 8.4.1.15. Rest of Middle East & Africa Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Manufacturer vs by Application Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Johnson & Johnson Services, Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Coloplast A/S
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Dipromed Srl
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Boston Scientific Corporation (American Medical Systems Inc.)
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. PFM medical ag
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Promedon Group
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Caldera Medical
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Cook Medical
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Medgyn Products, Inc.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Cooper Surgical, Inc.
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. DIMA S.L.
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. Digitimer Ltd.
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. Bray Group Ltd.
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development
    • 9.4.14. Medesign Ingenieur-Consulting GmbH
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Product Portfolio
      • 9.4.14.3. Financial Overview
      • 9.4.14.4. Business Strategies and Development
    • 9.4.15. Panpac Medical Corp.
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Product Portfolio
      • 9.4.15.3. Financial Overview
      • 9.4.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제